The decision to restart the oral solid dose products to US was based on the US Food and Drug Administration’s (FDA) decision to lift its import alert at Apotex’s manufacturing facility supplying product to the US.
Apotex COO Jeremy Desai said the company is pleased the FDA has recognized the enhancements to their global quality systems.
Apotex Inc is the patent company to US based Apotex Corp.
Through its sales and marketing headquarters in Weston, Florida and operations center in Indianapolis, Apotex Corp provides generic medicines.